Condition (MeSH)
Chronic Kidney Disease-Mineral and Bone Disorder
ClinicalTrials.gov lists 73 trials for Chronic Kidney Disease-Mineral and Bone Disorder or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
73 of the 73 trials are tagged with Chronic Kidney Disease-Mineral and Bone Disorder itself; the rest are tagged with a narrower condition beneath it.
When did Chronic Kidney Disease-Mineral and Bone Disorder trials start? (23)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 5 |
| 2025 | 6 |
| 2024 | 1 |
| 2023 | 3 |
| 2022 | 7 |
| 2021 | 4 |
| 2020 | 5 |
| 2019 | 2 |
| 2018 | 5 |
| 2017 | 2 |
Showing 10 of 23 earlier years.
No forecast is made for this condition: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 23 months across 33 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Chronic Kidney Disease-Mineral and Bone Disorder trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 12 |
| Phase 3 | 3 |
| Phase 4 | 9 |
| Not applicable | 11 |
| Observational | 36 |
How many Chronic Kidney Disease-Mineral and Bone Disorder trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 13 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 4 |
| Completed | 33 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Chronic Kidney Disease-Mineral and Bone Disorder trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| KAI Pharmaceuticals | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Amgen | 1 |
Which drugs are being tested for Chronic Kidney Disease-Mineral and Bone Disorder? (6)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Etelcalcetide | 3 |
| Sevelamer | 2 |
| Calcitriol | 2 |
| Antacid | 2 |
| Cinacalcet | 2 |
Showing 5 of 6 drugs.
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| CHOLECALCIFEROL | 3 |
| Paricalitol | 2 |
| Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule | 2 |
| Transdermal Teriparatide | 2 |
| Nicotinamide | 2 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Chronic Kidney Disease-Mineral and Bone Disorder trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| In patient | 9 | 1 |
| Pneumonia | 6 | 3 |
| AMI | 5 | 1 |
| Stroke | 5 | 1 |
| congestive heart failure | 4 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Chronic Kidney Disease-Mineral and Bone Disorder? (62)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). | The Cochrane database of systematic reviews | 2025 | Yes |
| Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2024 | Yes |
| Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023 | Yes |
| FGF-23 and sclerostin in serum and bone of CKD patients. | Clinical nephrology | 2023 | Yes |
| Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023 | Yes |
Showing 5 of 62 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.